JJ Hagan, DN Middlemiss, PC Sharpe… - Trends in pharmacological …, 1997 - cell.com
l-Dopa has long been the mainstay of therapy for Parkinson's disease but its long-term
shortcomings, principally uncoordinated, spasmodic or irregular movements (dyskinesias) and …